Open Access Peer-reviewed Research Article

Predictors of in-hospital mortality among patients with status epilepticus in Lubumbashi, Democratic Republic of the Congo: A retrospective study

Article Sidebar

Treatment protocol
Download PDF
Submitted   Jan 3, 2024
Published   Apr 4, 2024
Issue    Vol 5 No 1 (2023)
DOI   10.25082/AGPM.2023.01.003

Views

681

Downloads

237

Citations

PlumX Metrics

Main Article Content

Marcellin Bugeme
Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo
Olivier Mukuku corresponding author
Institut Supérieur des Techniques Médicales de Lubumbashi, Lubumbashi, Democratic Republic of the Congo
Lucien Nawej Ditend
Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo
Emmanuel Kiyana Muyumba
Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo
Béatrice Koba Bora
Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo

Abstract

Objective: Status Epilepticus (SE) is a condition characterized by an epileptic seizure that persists long enough or recurs at sufficiently short intervals to create a fixed and lasting epileptic condition. The objective of this study was to determine the prevalence and to identify predictors of in-hospital death among SE patients in Lubumbashi, Democratic Republic of the Congo (DRC).
Methods: We conducted a retrospective study from January 2020 to December 2022.
Results: Out of 3,006 patients admitted to the neurology department of the University Clinics of Lubumbashi, 97 presented with SE (i.e., a hospital prevalence of 3.23%). The mean age of the patients was 38.38±14.74 years, and men represented 77.3% of the cases. Epileptic patients represented 21.65% of the cases and 66.7% of them were on antiepileptic drugs (AEDs). Seizures were generalized in 72.16% of the patients. Seizures lasted 30 minutes or more in 50.52% of the cases. The most frequent etiologies were strokes, followed by central nervous system (CNS) infections. In-hospital mortality was 24.74% and the predictors of this mortality were CNS infections (adjusted OR = 22.34 [2.69-222.65]; p = 0.0006) and seizures lasting ≥ 30 minutes (adjusted OR = 10.98 [2.89-62.70]; p<0.0001).
Conclusion: SE is a major neurological emergency requiring early and multidisciplinary management to preserve the vital prognosis because, without treatment, SE causes important neurological complications and even death. The present study found a mortality of 24.74% which was associated with seizure duration of more than 30 minutes as well as with infectious etiologies.

Keywords
Status Epilepticus, mortality, Lubumbashi, DRC

Article Details

How to Cite
Bugeme, M., Mukuku, O., Ditend, L. N., Muyumba, E. K., & Bora, B. K. (2024). Predictors of in-hospital mortality among patients with status epilepticus in Lubumbashi, Democratic Republic of the Congo: A retrospective study. Advances in General Practice of Medicine, 5(1), 90-96. https://doi.org/10.25082/AGPM.2023.01.003
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. Alolayan YS, McKinley K, Bhatia R, et al. Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus. Journal of Clinical Medicine. 2021, 10(14): 3028. https://doi.org/10.3390/jcm10143028
  2. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015, 56(10): 1515-1523. https://doi.org/10.1111/epi.13121
  3. Newton CR, Kariuki SM. Status epilepticus in sub‐Saharan Africa: New findings. Epilepsia. 2013, 54(s6): 50-53. https://doi.org/10.1111/epi.12277
  4. Cisse FA, Tassiou NR, Barry SD, et al. Évaluation de la prise en charge des états de mal épileptiques convulsifs en milieu tropical. Revue Neurologique. 2017, 173: S45. https://doi.org/10.1016/j.neurol.2017.01.023
  5. Leitinger M, Trinka E, Zimmermann G, et al. Epidemiology of status epilepticus in adults: Apples, pears, and oranges — A critical review. Epilepsy & Behavior. 2020, 103: 106720. https://doi.org/10.1016/j.yebeh.2019.106720
  6. Ngugi AK, Kariuki SM, Bottomley C, et al. Incidence of epilepsy. Neurology. 2011, 77(10): 1005-1012. https://doi.org/10.1212/wnl.0b013e31822cfc90
  7. Kariuki SM, Kakooza-Mwesige A, Wagner RG, et al. Prevalence and factors associated with convulsive status epilepticus in Africans with epilepsy. Neurology. 2015, 84(18): 1838-1845. https://doi.org/10.1212/wnl.0000000000001542
  8. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000, 54(2): 340-340. https://doi.org/10.1212/wnl.54.2.340
  9. Dham BS, Hunter K, Rincon F. The Epidemiology of Status Epilepticus in the United States. Neurocritical Care. 2014, 20(3): 476-483. https://doi.org/10.1007/s12028-013-9935-x
  10. Ozdilek B, Midi I, Agan K, et al. Episodes of status epilepticus in young adults: Etiologic factors, subtypes, and outcomes. Epilepsy & Behavior. 2013, 27(2): 351-354. https://doi.org/10.1016/j.yebeh.2013.02.023
  11. Amare A, Zenebe G, Hammack J, et al. Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia. 2008, 49(4): 600-607. https://doi.org/10.1111/j.1528-1167.2008.01556.x
  12. Scholtes FBJ, Renier WO, Meinardi H. Status epilepticus in children. Seizure. 1996, 5(3): 177-184. https://doi.org/10.1016/s1059-1311(96)80033-1
  13. Eriksson K, Koivikko M. Status epilepticus in children: aetiology, treatment, and outcome. Developmental Medicine & Child Neurology. 1997, 39(10): 652-658. https://doi.org/10.1111/j.1469-8749.1997.tb07358.x
  14. Poursadeghfard M, Hashemzehi Z, Ashjazadeh N. Status Epilepticus in Adults: A 6-Year Retrospective Study. Galen Medical Journal. 2014, 3(3): e200. https://doi.org/10.31661/gmj.v3i3.200
  15. Akyuz E, Polat AK, Eroglu E, et al. Revisiting the role of neurotransmitters in epilepsy: An updated review. Life Sciences. 2021, 265: 118826. https://doi.org/10.1016/j.lfs.2020.118826
  16. Hanada T. Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors. Biomolecules. 2020, 10(3): 464. https://doi.org/10.3390/biom10030464
  17. Reddy Y, Balakrishna Y, Mubaiwa L. Convulsive status epilepticus in a quaternary hospital paediatric intensive care unit (PICU) in South Africa: An 8 year review. Seizure. 2017, 51: 55-60. https://doi.org/10.1016/j.seizure.2017.07.016
  18. Mbodj I, Ndiaye M, Sene F, et al. Prise en charge de l’état de mal épileptique dans les conditions de pays en développement. Neurophysiologie Clinique/Clinical Neurophysiology. 2000, 30(3): 165-169. https://doi.org/10.1016/s0987-7053(00)00203-3
  19. Moghaddasi M, Joodat R, Ataei E. Evaluation of Short-term Mortality of Status Epilepticus and Its Risk Factors. Journal of Epilepsy Research. 2015, 5(1): 13-16. https://doi.org/10.14581/jer.15003
  20. Langer JE, Fountain NB. A retrospective observational study of current treatment for generalized convulsive status epilepticus. Epilepsy & Behavior. 2014, 37: 95-99. https://doi.org/10.1016/j.yebeh.2014.06.008
  21. Lamine T, Moustapha N, Eva Sandrine KJ, et al. Assessment of State of Convulsive Child in Hospital National Children Albert Royer, Dakar. Clinical Pediatrics: Open Access. 2017, 02(01). https://doi.org/10.4172/2572-0775.1000116
  22. Nguefack S, Mbassi H D, Kouam M K, et al. Etiologies et évolution à court terme de l’état de mal convulsif inaugural du nourrisson et de l’enfant dans deux hôpitaux universitaires de Yaoundé (Cameroun). Health sciences and disease. 2016, 17(1). https://doi.org/10.5281/hsd.v17i1.568
  23. Thomas S, Cherian A. Status epilepticus. Annals of Indian Academy of Neurology. 2009, 12(3): 140. https://doi.org/10.4103/0972-2327.56312
  24. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990, 40(suppl 2): 13-23.
  25. Ramakrishnan KA, Levin M, Faust SN. Bacterial meningitis and brain abscess. Medicine. 2013, 41(12): 671-677. https://doi.org/10.1016/j.mpmed.2013.09.013
  26. Klein RS, Garber C, Howard N. Infectious immunity in the central nervous system and brain function. Nature Immunology. 2017, 18(2): 132-141. https://doi.org/10.1038/ni.3656
  27. Archibald LK, Quisling RG. Central Nervous System Infections. Textbook of Neurointensive Care. Published online 2013: 427-517. https://doi.org/10.1007/978-1-4471-5226-2_22
  28. Salimi H, Klein RS. Disruption of the Blood-Brain Barrier During Neuroinflammatory and Neuroinfectious Diseases. Neuroimmune Diseases. Published online 2019: 195-234. https://doi.org/10.1007/978-3-030-19515-1_7